This statistic shows the total revenues for contract research company IQVIA from 2013 to 2024, in million U.S. dollars. According to the company's last report in 2024, total revenues stood at some 15.4 billion U.S. dollars. IQVIA - formerly known as Quintiles and IMS Health, Inc. - is a U.S. company from Durham, North Carolina, active in clinical research and health IT.
This statistic shows the total revenue streams of contract researcher IQVIA from 2016 to 2024. In 2024, Technology & Analytics Solutions generated around *** billion U.S. dollars in revenue. IQVIA - formerly known as Quintiles and IMS Health, Inc. - is a U.S. company from Durham, North Carolina, active in clinical research and health IT.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IQVIA Holdings reported $249M in Net Income for its fiscal quarter ending in March of 2025. Data for IQVIA Holdings | IQV - Net Income including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IQVIA Holdings reported $2.7 in EPS Earnings Per Share for its fiscal quarter ending in March of 2025. Data for IQVIA Holdings | IQV - EPS Earnings Per Share including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IQVIA Holdings reported $492M in Operating Profit for its fiscal quarter ending in March of 2025. Data for IQVIA Holdings | IQV - Operating Profit including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IQVIA Holdings operating income for the twelve months ending March 31, 2025 was $2.192B, a 8.95% increase year-over-year. IQVIA Holdings annual operating income for 2024 was $2.202B, a 11.38% increase from 2023. IQVIA Holdings annual operating income for 2023 was $1.977B, a 9.89% increase from 2022. IQVIA Holdings annual operating income for 2022 was $1.799B, a 29.15% increase from 2021.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IQVIA Holdings reported $3.83B in Sales Revenues for its fiscal quarter ending in March of 2025. Data for IQVIA Holdings | IQV - Sales Revenues including historical, tables and charts were last updated by Trading Economics this last July in 2025.
The research revenue of IQVIA, one of the leading market research companies worldwide, increased steadily since 2013. In 2024, the company recorded a revenue of approximately **** billion U.S. dollars from this department.
The market research revenue of IQVIA in the United States increased significantly between 2013 and 2021. In 2021, the U.S. research company generated revenue of almost *** billion U.S. dollars in the United States, an increase of approximately *** million U.S. dollars compared to the previous year.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IQVIA Holdings ebit margin for the quarter ending March 31, 2025 was 14.14%. IQVIA Holdings average ebit margin for 2024 was 13.61%, a 7.76% increase from 2023. IQVIA Holdings average ebit margin for 2023 was 12.63%, a 3.52% increase from 2022. IQVIA Holdings average ebit margin for 2022 was 12.2%, a 39.75% increase from 2021. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
The net income of Iqvia Holdings with headquarters in the United States amounted to *** billion U.S. dollars in 2024. The reported fiscal year ends on December 31.Compared to the earliest depicted value from 2020 this is a total increase by approximately *** billion U.S. dollars. The trend from 2020 to 2024 shows, furthermore, that this increase happened continuously.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IQVIA Holdings reported $798M in EBITDA for its fiscal quarter ending in March of 2025. Data for IQVIA Holdings | IQV - Ebitda including historical, tables and charts were last updated by Trading Economics this last July in 2025.
https://okredo.com/en-lt/general-ruleshttps://okredo.com/en-lt/general-rules
UAB "IQVIA Commercial" financial data: profit, annual turnover, paid taxes, sales revenue, equity, assets (long-term and short-term), profitability indicators.
This statistic shows the annual net income of contract researcher IQVIA Holding Inc. from 2013 to 2024. In 2024, the net income of IQVIA was 1.37 billion U.S. dollars. IQVIA - formerly known as Quintiles and IMS Health, Inc. - is a U.S. company from Durham, North Carolina, active in clinical research and health IT.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IQVIA Holdings reported $689M in Pre-Tax Profit for its fiscal quarter ending in December of 2024. Data for IQVIA Holdings | IQV - Pre Tax Profit including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IQVIA Holdings return on equity for the quarter ending March 31, 2025 was 20.74. IQVIA Holdings average return on equity for 2024 was 21.99, a 9.57% decline from 2023. IQVIA Holdings average return on equity for 2023 was 20.07, a 1.93% increase from 2022. IQVIA Holdings average return on equity for 2022 was 19.69, a 72.87% increase from 2021. Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
https://www.kappasignal.com/p/legal-disclaimer.htmlhttps://www.kappasignal.com/p/legal-disclaimer.html
This analysis presents a rigorous exploration of financial data, incorporating a diverse range of statistical features. By providing a robust foundation, it facilitates advanced research and innovative modeling techniques within the field of finance.
Historical daily stock prices (open, high, low, close, volume)
Fundamental data (e.g., market capitalization, price to earnings P/E ratio, dividend yield, earnings per share EPS, price to earnings growth, debt-to-equity ratio, price-to-book ratio, current ratio, free cash flow, projected earnings growth, return on equity, dividend payout ratio, price to sales ratio, credit rating)
Technical indicators (e.g., moving averages, RSI, MACD, average directional index, aroon oscillator, stochastic oscillator, on-balance volume, accumulation/distribution A/D line, parabolic SAR indicator, bollinger bands indicators, fibonacci, williams percent range, commodity channel index)
Feature engineering based on financial data and technical indicators
Sentiment analysis data from social media and news articles
Macroeconomic data (e.g., GDP, unemployment rate, interest rates, consumer spending, building permits, consumer confidence, inflation, producer price index, money supply, home sales, retail sales, bond yields)
Stock price prediction
Portfolio optimization
Algorithmic trading
Market sentiment analysis
Risk management
Researchers investigating the effectiveness of machine learning in stock market prediction
Analysts developing quantitative trading Buy/Sell strategies
Individuals interested in building their own stock market prediction models
Students learning about machine learning and financial applications
The dataset may include different levels of granularity (e.g., daily, hourly)
Data cleaning and preprocessing are essential before model training
Regular updates are recommended to maintain the accuracy and relevance of the data
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IQVIA Holdings reported $13.11B in Loan Capital for its fiscal quarter ending in March of 2025. Data for IQVIA Holdings | IQV - Loan Capital including historical, tables and charts were last updated by Trading Economics this last July in 2025.
https://okredo.com/en-lt/general-ruleshttps://okredo.com/en-lt/general-rules
IQVIA RDS UAB financial data: profit, annual turnover, paid taxes, sales revenue, equity, assets (long-term and short-term), profitability indicators.
The operating profit of Iqvia Holdings with headquarters in the United States amounted to *** billion U.S. dollars in 2024. The reported fiscal year ends on December 31.Compared to the earliest depicted value from 2020 this is a total increase by approximately *** billion U.S. dollars. The trend from 2020 to 2024 shows, furthermore, that this increase happened continuously.
This statistic shows the total revenues for contract research company IQVIA from 2013 to 2024, in million U.S. dollars. According to the company's last report in 2024, total revenues stood at some 15.4 billion U.S. dollars. IQVIA - formerly known as Quintiles and IMS Health, Inc. - is a U.S. company from Durham, North Carolina, active in clinical research and health IT.